SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-04-000477
Filing Date
2004-02-17
Accepted
2004-02-17 16:34:47
Documents
4
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS EC, L.L.C.PERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.PERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM AH LLCSFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sc13ga1-allos.txt SC 13G/A 38494
3 EXHIBIT 1 ex1_sc13ga1-allos.txt EX-99 6837
4 EXHIBIT 2 ex2_sc13ga1-allos.txt EX-24 2559
5 EXHIBIT 3 ex3_sc13ga1-allos.txt EX-24 2253
  Complete submission text file 0000950142-04-000477.txt   52927
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 7000 NORTH BROADWAY SUITE 400 DENVER CO 80221
Business Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 3034266262
ALLOS THERAPEUTICS INC (Subject) CIK: 0001097264 (see all company filings)

IRS No.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60251 | Film No.: 04609298
SIC: 2834 Pharmaceutical Preparations